Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Candidate tumor supressor.. Additionally we are shipping and many more products for this protein.
Showing 10 out of 17 products:
Human Polyclonal DEC1 Primary Antibody for ICC, IF - ABIN151308
Ralph, Parham, Lee, Beard, Craigon, Ward, White, Barber, Rayner, Kingsman, Mundy, Mazarakis, Krige: Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1 alpha and HIF-2 alpha in a primary neuronal model of hypoxia. in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2004
Show all 9 references for 151308
Human Polyclonal DEC1 Primary Antibody for IHC (p), WB - ABIN4304698
Donninger, Calvisi, Barnoud, Clark, Schmidt, Vos, Clark: NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. in The Journal of cell biology 2015
Dec1 (show BHLHE40 Antibodies) is a prognostic factor for the clinical outcome and a predictive factor for the response to TMZ chemotherapy in patients with glioma.
decreases of CES and CYP3A4 (show CYP3A4 Antibodies) expression and enzymatic activities induced by Fluoxetine are through decreasing PXR (show NR1I2 Antibodies) and increasing DEC1 (show BHLHE40 Antibodies) in HepG2 cells
DEC1 (show BHLHE40 Antibodies) is down-regulated and tends to contribute to the migration ability of tumor cell lines; H3 K27 (show KRT27 Antibodies) trimethylation potentially plays an important role in the regulation of DEC1 (show BHLHE40 Antibodies) expression
DEC1 (show BHLHE40 Antibodies) promoter -249 T>C (rs2012775) polymorphism is functional, modulating susceptibility to squamous cell carcinoma of the head and neck (SCCHN) among non-Hispanic Whites.
DEC1 (show BHLHE40 Antibodies) is a candidate tumor suppressor gene that may be involved in esophageal squamous cell carcinoma development
Decreased expression of candidate DEC1 (show BHLHE40 Antibodies) is associated with esophageal carcinoma
Candidate tumor supressor.
candidate tumor suppressor CTS9
, deleted in esophageal cancer 1